Bull case
PM would need investors to value it at roughly 31x earnings — about 10x more generous than today's 21x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where PM stock could go
PM would need investors to value it at roughly 31x earnings — about 10x more generous than today's 21x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
This is close to how the market is already pricing PM — at roughly 24x forward earnings. No dramatic re-rating needed, just steady execution on the core business.
If investor confidence fades or macro conditions deteriorate, a 6x multiple contraction could push PM down roughly 30% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Philip Morris International is a global tobacco company transitioning from traditional cigarettes to smoke-free alternatives like heated tobacco and vaping products. It generates revenue primarily from cigarette sales — still about two-thirds of total — with the remainder from smoke-free products sold in over 70 markets worldwide. The company's key advantage is its dominant Marlboro brand equity and extensive international distribution network, which it leverages to convert smokers to its higher-margin smoke-free portfolio.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $1.91/$1.86 | +2.7% | $10.1B/$10.3B | -1.7% |
| Q4 2025 | $2.24/$2.09 | +7.2% | $10.8B/$10.6B | +2.0% |
| Q1 2026 | $1.70/$1.70 | +0.0% | $10.4B/$10.4B | -0.4% |
| Q2 2026 | $1.96/$1.86 | +5.4% | $10.1B/$10.0B | +1.9% |
PM beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $105 — implies -41.4% from today's price.
| Metric | PM | S&P 500 | Consumer Defensive | 5Y Avg PM |
|---|---|---|---|---|
| Forward PE | 21.3x | 18.8x+13% | 14.2x+50% | — |
| Trailing PE | 24.6x | 24.4x | 18.9x+30% | 20.2x+21% |
| PEG Ratio | 3.48x | 1.66x+110% | 1.92x+81% | — |
| EV/EBITDA | 19.0x | 15.2x+25% | 11.1x+72% | 14.8x+28% |
| Price/FCF | 26.1x | 20.7x+26% | 15.3x+71% | 17.7x+47% |
| Price/Sales | 6.8x | 3.1x+121% | 0.9x+677% | 5.0x+37% |
| Dividend Yield | 3.10% | 1.91% | 3.06% | 4.67% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolPM generates $10.7B in free cash flow at a 25.7% margin — 33.2% ROIC signals a durable competitive advantage · returns 3.1% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~4.1 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 17, 2026
Philip Morris International reduced its 2026 EPS guidance due to currency pressures and a $500 million non-cash impairment related to its Canadian affiliate.
The company faces regulatory challenges, including excise taxes and litigation, which could impact its long-term ambitions and smoke-free strategy.
Currency fluctuations are cited as a significant factor affecting earnings, particularly in international markets.
Counterfeit cigarettes are driving the illicit market in the EU above 10%, posing a threat to legitimate sales.
The transition to smoke-free products like IQOS and ZYN carries execution risks, including market adoption and regulatory hurdles.
Philip Morris International's valuation multiples may reflect risks related to earnings growth, profit margins, and industry challenges.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 17, 2026
Management highlights IQOS and ZYN as primary drivers of future growth, shifting focus away from traditional tobacco products.
PM's trailing and forward P/E ratios of 23.36 and 18.83 respectively indicate solid earnings potential and valuation support.
The stock has already appreciated 6% since the bullish thesis was presented, suggesting continued upside momentum.
Near-term sentiment swings are influenced by competition in IQOS and ZYN markets, particularly in Japan, indicating investor focus on innovation.
While impairments like the $500 million charge for Rothmans, Benson & Hedges weigh on earnings, they reflect strategic adjustments rather than core operational weakness.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
PM PM Philip Morris International Inc. | $278.0B | 21.3x | +5.2% | 26.7% | Buy | +6.3% |
MO MO Altria Group, Inc. | $115.6B | 12.2x | -1.6% | 36.9% | Buy | +3.9% |
BTI BTI British American Tobacco p.l.c. | $127.8B | 16.5x | -0.3% | -20.8% | Buy | -32.1% |
XXI XXII 22nd Century Group, Inc. | $2M | — | -19.8% | -44.9% | — | — |
TPV TPVG TriplePoint Venture Growth BDC Corp. | $203M | 5.3x | +17.0% | -19.5% | Hold | +79.0% |
UVV UVV Universal Corporation | $1.3B | 12.5x | +1.7% | 1.1% | Buy | — |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
PM returns 3.1% total yield, led by a 3.10% dividend, raised 18 consecutive years.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $2.94 | — | — | — |
| 2025 | $5.64 | +6.4% | 0.0% | 3.5% |
| 2024 | $5.30 | +3.1% | 0.0% | 4.4% |
| 2023 | $5.14 | +2.0% | 0.0% | 5.5% |
| 2022 | $5.04 | +2.9% | 0.1% | 5.1% |
Common questions answered from live analyst data and company financials.
Philip Morris International Inc. (PM) is rated Buy by Wall Street analysts as of 2026. Of 25 analysts covering the stock, 17 rate it Buy or Strong Buy, 7 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $190, implying +6.3% from the current price of $178. The bear case scenario is $125 and the bull case is $260.
The Wall Street consensus price target for PM is $190 based on 25 analyst estimates. The high-end target is $205 (+14.9% from today), and the low-end target is $168 (-5.8%). The base case model target is $198.
PM trades at 21.3x times forward earnings. The stock's valuation is broadly in line with the broader market. Based on current multiples versus the peer group, the relative model signals expensive versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for PM in 2026 are: (1) Earnings Guidance Cut — Philip Morris International reduced its 2026 EPS guidance due to currency pressures and a $500 million non-cash impairment related to its Canadian affiliate. (2) Regulatory Risks — The company faces regulatory challenges, including excise taxes and litigation, which could impact its long-term ambitions and smoke-free strategy. (3) Foreign Exchange Pressures — Currency fluctuations are cited as a significant factor affecting earnings, particularly in international markets. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates PM will report consensus revenue of $43.7B (+5.2% year-over-year) and EPS of $7.66 (+7.9% year-over-year) for the upcoming fiscal year. The following year, analysts project $45.4B in revenue.
Philip Morris International Inc. is expected to report its next earnings on approximately 2026-07-22. Consensus expects EPS of $2.06 and revenue of $10.6B. Over recent quarters, PM has beaten EPS estimates 83% of the time.
Philip Morris International Inc. (PM) generated $10.7B in free cash flow over the trailing twelve months — a free cash flow margin of 25.7%. PM returns capital to shareholders through dividends (3.1% yield) and share repurchases ($0 TTM).